Combating Illicit Xylazine Act aims to control xylazine by scheduling it as a controlled substance and updating related regulations.
The Combating Illicit Xylazine Act seeks to address the misuse of xylazine by placing it under the Controlled Substances Act's schedule III. This includes defining xylazine, updating labeling and distribution logistics, and exempting certain manufacturers from specific security requirements. The Act also mandates the United States Sentencing Commission to review and amend sentencing guidelines for xylazine-related offenses.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.